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Aim: This survey is performed to learn about the structure of radiotherapy in México.
Background: Radiation oncology practice is increasing because of the higher incidence of
cancer. There is no published data about radiotherapy in México.
Materials and methods: A questionnaire was sent to the 83 registered centers in the database
of  the Mexican regulatory agency. One out of the 32 states has no radiotherapy. 27 centers
from 14 states provided their answers.
Results: 829 patients are treated annually with any radiotherapy modality in each center. Two
centers have one cobalt machine, 7 have a cobalt and a linac and 10 have more than one linac.
Five centers use 2D planning systems, 22 use 3D; 9, conventional simulators; 22, CT based
simulation, and 1 center has no simulation. Most of the centers verify beams with ﬁlms,
electronic portal image devices and cone beam CTs are also used. Intensity modulated and
image  guided radiotherapy are performed in 5 states. Breast, prostate, cervix, lung, rectum
and  head and neck cancer are the six most common locations. There are 45 public and
38  private centers, 2 dedicated to children. Two gamma knife units, 5 Novalis systems, 1
tomotherapy and 2 cyberknife machines are working. All centers have at least one radiation
oncologist, one physicist and one radiotherapist.Conclusions: Deﬁnitive conclusions cannot be drawn from this limited feedback due to a low
participation of centers. This survey about radiotherapy in Mexico shows the heterogeneity
of  equipment as well as medical and technical staff in the whole country.
©  2012 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
plines and provide ways to enhance future surveys. Surveys.  Background
he increase in the use of ionizing radiation for cancer
reatment is a worldwide phenomenon, because of a higher
ncidence as the life expectancy increases as well as earlier
iagnoses and treatments.
Surveys could show patterns of care across the world and
ould be useful to improve the availability and quality of
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health care. Based on them, it is possible to create processes
to develop measurements of quality of care, to deﬁne practice
standards, to identify areas in need of improvement and
to continuously assess accomplishments, based on clinical
parameters. Results can create collaboration among disci-47210.
may be directed to the structure (equipment and personnel),
process (how patients are evaluated and treated) and outcome
(results for patients).1
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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The International Atomic Energy Agency (IAEA) carried out
in 2004 a general survey of RT equipment, facilities and stafﬁng
in Latin America for infrastructure.2
There are no studies in México that examine patterns of
practice for radiation oncology.
2.  Aim
Given the lack of current data on patterns of care in this disci-
pline in Mexico, we  performed the present study focusing on
the structure.
3. Materials  and  methods
This is a descriptive pattern of care survey. It was conducted
through a questionnaire directly sent electronically to each
radiotherapy center, institute and public and private hospital
using the data base from registered services in the National
Commission of Nuclear Security and Safeguards (CNSNS),3
which is the regulatory agency in México to health providers
and to venders. The information regarding radiation oncolo-
gists was obtained from the Mexican Certiﬁcation Board on
Radiotherapy AC (CMCR).
4.  Results
A total of 83 Mexican centers are included in the CNSNS data
base. There are radiotherapy centers in all the states except
two: Tlaxcala and Quintana Roo, in the latter, the installation
of the ﬁrst linac is taking place.
There are two centers in Mexico City specialized in children
(aged up to 18 years).
27 centers answered the questionnaire, from 14 states:
Mexico City 7 centers, Nuevo León 3 centers, Guanajuato 3
centers, Tamaulipas 2 centers, Jalisco 2 centers and single
centers from Estado de México, Hidalgo, Querétaro, Sonora,
Chihuahua, Coahuila, Colima, Aguascalientes, Puebla and
Morelos.
The mean number of patients per year in all radiotherapy
modalities is 829 (350–2177).
4.1.  Facilities  and  equipment
There are 2 gamma knife units in the country and ﬁve dedi-
cated Novalis systems for intracranial diseases. There is one
tomotherapy unit in the north of the country and 2 cyber-knife
machines, one in Mexico City and one in the northeast of the
country. Intensity modulated radiotherapy and Image  Guided
radiotherapy is used in 5 states.
Low dose rate brachytherapy with iodine for prostate is
performed in 2 centers, both in México City.
Information about brachytherapy revealed that treatments
with low dose rate cesium sources manual applications and
high dose rate iridium afterloading systems are performed,
both primarily for gynecological treatments.
The responses of the 27 centers showed that there are 2
facilities equipped only with cobalt machines and 7 centers
with both cobalt machines and linacs. Recently, the use ofdiotherapy 1 8 ( 2 0 1 3 ) 57–60
Linacs have become more  common, currently there are 40 of
them. 10 centers have more  than one linac, 3 have three and
one has 4.
The information from venders show: Elekta, 13 linacs work-
ing and 9 in the process of installation, Varian, 33 and 10,
respectively, and Siemens 8 linacs working.
There are 5 centers that use 2D planning systems, the oth-
ers use 3D. There are 9 conventional simulators, CT based
simulation is performed in 22 centers; one center has no sim-
ulation at all. Most of the centers verify beams with ﬁlms, but
there are electronic portal image  devices and cone beam CTs.
4.2.  Anatomical  sites  treated
One of the centers that responded is a children’s hospital,
5 most frequent locations treated there are Medulloblas-
toma, astrocytomas, Rabdomyosarcomas, Wilms tumors and
Retinoblastoma. The responses from the rest of the centers
show that breast cancer is the most frequent location in 23
centers. Prostate cancer is the ﬁrst cause in one center and the
second cause in 19, cervix uteri is the ﬁrst cause of radiation
in 2 centers and the second cause in 8, which shows the epi-
demiological change in this country. Lung cancer is the second
cause in 2 centers and the third cause in 8. Regarding gastroin-
testinal tumors, the 4th tumor most treated with radiotherapy
in 17 centers is rectum and in 2, stomach cancer. Head and
neck cancer is the ﬁfth cause in 9 centers, lymphoma in 6
centers, metastases and central nervous system tumours in
2 centers.
4.3.  Workloads  and  stafﬁng  levels
Most of the centers9 work 16 h, 9 centers work 12 h, 3 centers
work 8, 10 and 14 h, respectively.
The Board has 217 certiﬁcated radiation oncologists, 17
have passed away. There were 42 women, 175 men.
The numbers of medical physicists employed are the fol-
lowing: 1 in 9 centers, 2 in 7, 3 in 4, 4 in 3, 5 in 1, and 6 in 2.
The centers with more  physicists are public, with more  than
one machine.
Three centers have one technician per machine, the oth-
ers have more  than one and there are 5 dosimetrists. In some
cases radiotherapists have a self-trainee education; they are
radiology technicians who work in radiotherapy, otherwise
they receive training in a dedicated oncology institution.
4.4.  Type  of  cancer  center
The CNSNS database has 45 public and 38 private registered
centers. There are six centers, 3 in México City and 3 in other
regions of the country, where radiation oncologists are trained.
Medical physicists obtain the master degree in 2 public univer-
sities.
5.  DiscussionThis study yields preliminary, detailed information on human
and material resources available for radiotherapy in México.
To our knowledge, the current report is the ﬁrst to describe
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atterns of clinical practice for radiotherapy in México. The
ata presented here is unique and provide useful information
bout the current state of radiotherapy in México.
Studies on a pattern of care allow to draw reliable pic-
ure of current status of radiotherapy delivery in a country
r region.4–10 The results support the comparison with other
ountries and arise awareness in the society and authori-
ies. Such effort leads to improvement and optimization of
rganization of delivery of radiotherapy and may improve
he treatment outcome.11–16 Radiotherapy is an essential
art of the treatment of cancer. Patients with cancer in low
nd middle-income regions could have a greater need for
adiotherapy because of the more  advanced stage at presen-
ation. They also need more  extensive social support.17–19
afe and effective development of services would beneﬁt from
inks with established facilities in other countries, access to
nformation, such as free online journal access and better
ducation of all medical staff about roles and beneﬁts of
adiotherapy.20
According to the World Bank, México is a medium
ncome country, the second largest in Latin America,21 with
,964,375 km2 and the population of 112,336,538 in 2010,
ncluding 48% of men  and 52% of women. There is a demo-
raphic transition where the population pyramid is growing
owards adult age. There are 32 states in the country; the
ost densely populated are México City and the state of
éxico, which surrounds the city. Cancer is the second
eading cause of death in Mexico after cardiovascular dis-
ases. In 2008, the age-world-standardized incidence rate
ASR (W)) per 100,000 for cancer incidence in Mexico was
28.4, not including non-melanoma skin cancer. A total of
27,600 new cancer cases were diagnosed. The main causes
f death from cancer in males are lung, prostate, and stom-
ch primaries, while for females, breast, cervical, and liver
ancers.22,23
According to Globocan 2008, the estimated age-
tandardized incidence and mortality rates for both sexes
howed that the most frequent tumor locations are prostate,
reast, cervix uteri, lung and stomach.24
In this survey, breast cancer accounted for the vast majority
f treatments. As described elsewhere, radiation therapy has
 fundamental role in patients with locally advanced breast
ancer after initial systemic treatment and surgery, as well as
n those diagnosed early for conservative approach. In patients
ith metastatic disease to the bone, brain and soft tissue,
adiation is an effective tool for palliation.25–27
In particular, for gynecological tumors, the cervix uteri and
he endometrium, were the two most common sites, requiring
n most cases the combination of external radiotherapy and
rachytherapy. A descriptive survey on brachytherapy in Latin
merica has been already published by Guedea et al.28
Among the male tumors, prostate is the most frequent one
nd most cases are treated with external beam irradiation,
aybe because brachytherapy is available only in a few centers
nd the majority of the cases are presented for adjuvant or
alvage treatment,29 however, this subject is beyond the scope
f this article.Another issue of importance is to make a reasonable and
edical evidence-based balance justifying the purchase and
mplementation of the newest technology in the region ofiotherapy 1 8 ( 2 0 1 3 ) 57–60 59
limited resources where foremost attention has to be directed
to provide the cancer care to all society members.12,13,30–32
6.  Conclusions
Unfortunately, the main limitation of this study is the low par-
ticipation of some centers, explained in some cases because of
a busy schedule, lack of interest or technological issues. There-
fore, we cannot draw deﬁnitive conclusions for this limited
feedback. We  received reliable information regarding the cur-
rent status of the structure process of radiotherapy in Mexico
that gives us a general idea of the heterogeneity of equipment
and kinds of treatments, as well as medical and technical staff
in the whole country.
7.  Future  actions
A more  sample data regarding the structure, process and out-
come in radiation oncology in Mexico has to be collected in
a near future, by motivation of doctors and by an accessible
method to obtain information. A next attempt could focus on
obtaining a wider database regarding the process of care.
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Appendix.
Lesbia Rivera (Centro Oncológico Estatal ISSEMYN), Hey-
nar Pérez (Hospital infantil de México Federico Gómez),
Mario Rodríguez (Centro Oncológico de Qro. Sade y Sucur-
sal Pachuca), Vinicio Toledo (Hospital San Javier), Aurora
Aldana (Hospital Angeles del Pedregal), Marco  Ramírez (Hos-
pital Regional De Alta Especialidad Del Bajío), Rosalía Souto
(Unidad Medica De Alta Especialidad IMSS UMAE 1 León
Guanajuato), Jorge Rodríguez Peral (Hospital Regional No.
1, IMSS, Cd. Obregón, Son., Oncoservicios de los Mochis,
RadioOncología San José), Luis Bayardo (Centro Médico de
Occidente), Armando Fernández (Centro Médico Nacional “20
De Noviembre” ISSSTE). Manuel Flores (INCan), Julia Sáenz
(Hospital UMAE 25, IMSS, Christus Muguerza Alta Especial-
idad), Francisco Velasco (Centro Oncológico de Tamaulipas,
Centro de Radioterapia de Tampico), Mauricio Durán (Insti-
tuto Estatal de Cancerología Colima), Javier Aguirre (Centro
Oncológico de Chihuahua/CIMA), Lázaro Gómez (Servicios
Oncológicos De Aguascalientes), Enrique Ventura (UMAE HEde Oncologia SSA, Puebla UMAE), Federico Maldonado (Servi-
cio de Radioterapia del Hospital Central Militar), Héctor Cortés
(Instituto Oncológico de Morelos).
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